- call +1-201-465-4211
- email sales@mrinsights.biz
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
Scope of the Report:
The classification of vaccine adjuvants includes veterinary vaccine adjuvants and human vaccine adjuvants. And the proportion of human vaccine adjuvants in 2016 is about 52.4%. The veterinary vaccine adjuvants in 2015 are about 47.6%.
The classification of Veterinary Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2016 is about 56.3%. The Subcutaneous in 2016 is about 29%.
The classification of Human Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2016 is about 55.5%. The Subcutaneous in 2016 is about 28.8%.
The worldwide market for Vaccine Adjuvants is expected to grow at a CAGR of roughly 10.3% over the next five years, will reach 1010 million US$ in 2024, from 560 million US$ in 2019, according to a new study.
This report focuses on the Vaccine Adjuvants in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
SEPPIC
SDA BIO
Brenntag Biosector
SPI Pharma
MVP Laboratories
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL Limited
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
Subcutaneous
Intramuscular
Others
Market Segment by Applications, can be divided into
Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
Human Vaccine Adjuvants (Research Applications, Commercial Applications)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccine Adjuvants product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vaccine Adjuvants, with price, sales, revenue and global market share of Vaccine Adjuvants in 2017 and 2018.
Chapter 3, the Vaccine Adjuvants competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine Adjuvants breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Vaccine Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Vaccine Adjuvants sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Vaccine Adjuvants Introduction
1.2 Market Analysis by Type
1.2.1 Oral
1.2.2 Subcutaneous
1.2.3 Intramuscular
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
1.3.2 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 SEPPIC
2.1.1 Business Overview
2.1.2 Vaccine Adjuvants Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 SDA BIO
2.2.1 Business Overview
2.2.2 Vaccine Adjuvants Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 SDA BIO Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Brenntag Biosector
2.3.1 Business Overview
2.3.2 Vaccine Adjuvants Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 SPI Pharma
2.4.1 Business Overview
2.4.2 Vaccine Adjuvants Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 MVP Laboratories
2.5.1 Business Overview
2.5.2 Vaccine Adjuvants Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Tj Kaiwei
2.6.1 Business Overview
2.6.2 Vaccine Adjuvants Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Novavax
2.7.1 Business Overview
2.7.2 Vaccine Adjuvants Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Zhuoyue
2.8.1 Business Overview
2.8.2 Vaccine Adjuvants Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Aphios
2.9.1 Business Overview
2.9.2 Vaccine Adjuvants Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 GSK
2.10.1 Business Overview
2.10.2 Vaccine Adjuvants Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 GSK Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 CSL Limited
2.11.1 Business Overview
2.11.2 Vaccine Adjuvants Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 CSL Limited Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Brenntag Biosector
2.12.1 Business Overview
2.12.2 Vaccine Adjuvants Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 SEPPIC
2.13.1 Business Overview
2.13.2 Vaccine Adjuvants Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 SPI Pharma
2.14.1 Business Overview
2.14.2 Vaccine Adjuvants Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Novavax
2.15.1 Business Overview
2.15.2 Vaccine Adjuvants Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Avanti Polar Lipids
2.16.1 Business Overview
2.16.2 Vaccine Adjuvants Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.17 Aphios
2.17.1 Business Overview
2.17.2 Vaccine Adjuvants Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Vaccine Adjuvants Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Vaccine Adjuvants Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Vaccine Adjuvants Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Vaccine Adjuvants Manufacturer Market Share in 2018
3.3.2 Top 6 Vaccine Adjuvants Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Vaccine Adjuvants Market Analysis by Regions
4.1 Global Vaccine Adjuvants Sales, Revenue and Market Share by Regions
4.1.1 Global Vaccine Adjuvants Sales and Market Share by Regions (2014-2019)
4.1.2 Global Vaccine Adjuvants Revenue and Market Share by Regions (2014-2019)
4.2 North America Vaccine Adjuvants Sales and Growth Rate (2014-2019)
4.3 Europe Vaccine Adjuvants Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Vaccine Adjuvants Sales and Growth Rate (2014-2019)
4.5 South America Vaccine Adjuvants Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Vaccine Adjuvants Sales and Growth Rate (2014-2019)
5 North America Vaccine Adjuvants by Country
5.1 North America Vaccine Adjuvants Sales, Revenue and Market Share by Country
5.1.1 North America Vaccine Adjuvants Sales and Market Share by Country (2014-2019)
5.1.2 North America Vaccine Adjuvants Revenue and Market Share by Country (2014-2019)
5.2 United States Vaccine Adjuvants Sales and Growth Rate (2014-2019)
5.3 Canada Vaccine Adjuvants Sales and Growth Rate (2014-2019)
5.4 Mexico Vaccine Adjuvants Sales and Growth Rate (2014-2019)
6 Europe Vaccine Adjuvants by Country
6.1 Europe Vaccine Adjuvants Sales, Revenue and Market Share by Country
6.1.1 Europe Vaccine Adjuvants Sales and Market Share by Country (2014-2019)
6.1.2 Europe Vaccine Adjuvants Revenue and Market Share by Country (2014-2019)
6.2 Germany Vaccine Adjuvants Sales and Growth Rate (2014-2019)
6.3 UK Vaccine Adjuvants Sales and Growth Rate (2014-2019)
6.4 France Vaccine Adjuvants Sales and Growth Rate (2014-2019)
6.5 Russia Vaccine Adjuvants Sales and Growth Rate (2014-2019)
6.6 Italy Vaccine Adjuvants Sales and Growth Rate (2014-2019)
7 Asia-Pacific Vaccine Adjuvants by Country
7.1 Asia-Pacific Vaccine Adjuvants Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Vaccine Adjuvants Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Vaccine Adjuvants Revenue and Market Share by Country (2014-2019)
7.2 China Vaccine Adjuvants Sales and Growth Rate (2014-2019)
7.3 Japan Vaccine Adjuvants Sales and Growth Rate (2014-2019)
7.4 Korea Vaccine Adjuvants Sales and Growth Rate (2014-2019)
7.5 India Vaccine Adjuvants Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Vaccine Adjuvants Sales and Growth Rate (2014-2019)
8 South America Vaccine Adjuvants by Country
8.1 South America Vaccine Adjuvants Sales, Revenue and Market Share by Country
8.1.1 South America Vaccine Adjuvants Sales and Market Share by Country (2014-2019)
8.1.2 South America Vaccine Adjuvants Revenue and Market Share by Country (2014-2019)
8.2 Brazil Vaccine Adjuvants Sales and Growth Rate (2014-2019)
8.3 Argentina Vaccine Adjuvants Sales and Growth Rate (2014-2019)
8.4 Colombia Vaccine Adjuvants Sales and Growth Rate (2014-2019)
9 Middle East and Africa Vaccine Adjuvants by Countries
9.1 Middle East and Africa Vaccine Adjuvants Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Vaccine Adjuvants Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Vaccine Adjuvants Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Vaccine Adjuvants Sales and Growth Rate (2014-2019)
9.3 Turkey Vaccine Adjuvants Sales and Growth Rate (2014-2019)
9.4 Egypt Vaccine Adjuvants Sales and Growth Rate (2014-2019)
9.5 Nigeria Vaccine Adjuvants Sales and Growth Rate (2014-2019)
9.6 South Africa Vaccine Adjuvants Sales and Growth Rate (2014-2019)
10 Global Vaccine Adjuvants Market Segment by Type
10.1 Global Vaccine Adjuvants Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Vaccine Adjuvants Sales and Market Share by Type (2014-2019)
10.1.2 Global Vaccine Adjuvants Revenue and Market Share by Type (2014-2019)
10.2 Oral Sales Growth and Price
10.2.1 Global Oral Sales Growth (2014-2019)
10.2.2 Global Oral Price (2014-2019)
10.3 Subcutaneous Sales Growth and Price
10.3.1 Global Subcutaneous Sales Growth (2014-2019)
10.3.2 Global Subcutaneous Price (2014-2019)
10.4 Intramuscular Sales Growth and Price
10.4.1 Global Intramuscular Sales Growth (2014-2019)
10.4.2 Global Intramuscular Price (2014-2019)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2014-2019)
10.5.2 Global Others Price (2014-2019)
11 Global Vaccine Adjuvants Market Segment by Application
11.1 Global Vaccine Adjuvants Sales Market Share by Application (2014-2019)
11.2 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2014-2019)
11.3 Human Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2014-2019)
12 Vaccine Adjuvants Market Forecast (2019-2024)
12.1 Global Vaccine Adjuvants Sales, Revenue and Growth Rate (2019-2024)
12.2 Vaccine Adjuvants Market Forecast by Regions (2019-2024)
12.2.1 North America Vaccine Adjuvants Market Forecast (2019-2024)
12.2.2 Europe Vaccine Adjuvants Market Forecast (2019-2024)
12.2.3 Asia-Pacific Vaccine Adjuvants Market Forecast (2019-2024)
12.2.4 South America Vaccine Adjuvants Market Forecast (2019-2024)
12.2.5 Middle East and Africa Vaccine Adjuvants Market Forecast (2019-2024)
12.3 Vaccine Adjuvants Market Forecast by Type (2019-2024)
12.3.1 Global Vaccine Adjuvants Sales Forecast by Type (2019-2024)
12.3.2 Global Vaccine Adjuvants Market Share Forecast by Type (2019-2024)
12.4 Vaccine Adjuvants Market Forecast by Application (2019-2024)
12.4.1 Global Vaccine Adjuvants Sales Forecast by Application (2019-2024)
12.4.2 Global Vaccine Adjuvants Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Vaccine Adjuvants Picture
Table Product Specifications of Vaccine Adjuvants
Figure Global Sales Market Share of Vaccine Adjuvants by Types in 2018
Table
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
